The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities.

• Cybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication

• FDA removes REMS requirements for embryofetal toxicity risk from all endothelin receptor antagonist medicines

• FDA Advises Consumers Not to Inhale Nitrous Oxide Products. Due to Potential for Severe Adverse Events if Used for Recreational/Non-Food Purposes

…

Sign Up for Free Trial

---

• Back
• MCN Blog